Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies

Home | Video pages | Webcast | Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease

Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease